Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a promising treatment for weight management and metabolic control [6]
Lazzer S, Grugni G, Tringali G, Sartorio A
These individuals should be offered initial modified-release metformin and an SGLT2 inhibitor, with consideration also given to adding a GLP-1 RA (liraglutide, dulaglutide, or oral or subcutaneous semaglutide) or tirzepatide
Because we believe that after the treatment, there must be clear results
(286) conducted a randomized crossover trial in 28 patients with CKD stages 34, demonstrating that a 4-week Mediterranean diet intervention did not result in elevated serum potassium levels (no significant difference pre- and post-intervention) and maintained stable renal function, confirming the safety and feasibility of the Mediterranean diet in CKD patients
Can I see Amino USA lab reports before purchasing